Summarized by Masters of Longevity from Longevity Technology.
Study will measure low-abundance proteins years before neurodegenerative diagnoses.
Key Takeaways
- UK Biobank is measuring proteins in 80,000 stored samples.
- Proteomic data are being linked with genetics and imaging.
- Population sampling bias has not been fully resolved.
